Reuters’ Paratek-To-Merck-Vs.-Hospira Patent Reporting: Confused — But I’m Out Of Time, Today.

The usually reliable Reuters service put out an overnight story — on Hospira’s attempts (now owned by Pfizer) to launch a generic version of Invanz® (purporting to cover the patent spats involved) — that is (at best) confusing.

Here is the full memorandum opinion (a 49 page PDF file) from last Friday in Delaware federal District Court.

You should read it for yourself — but the upshot is that it will be immaterial to Kenilworth.

If and when I find some quiet time, I’ll be back to explain what’s really going on here. Until then — best to all. As ever, life intervenes — smile. . .



There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: